Vaxcyte, Inc.

PCVX

Vaxcyte, Inc.

PCVX

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-26Shares Purchased (TTM):0Shares Sold (TTM):97,601

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:146,775,945Shares Outstanding:139,506,680Institutional Ownership Pct.:105.21%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	183	261	174	281	307	347	388	1,050	519	612	397	545
Short Term Investments	1,304	1,476	1,387	1,430	1,355	1,325	1,359	1,130	934	875	683	721
Prepaid Expense And Other Assets Current	66	76	66	56	54	45	41	33	29	31	16	30
Assets Current	1,553	1,813	1,627	1,767	1,716	1,717	1,788	2,214	1,481	1,517	1,096	1,295
Property Plant And Equipment Net	260	261	257	253	242	217	198	163	126	85	80	11
Operating Lease Right Of Use Asset	110	113	116	84	86	88	72	29	27	29	31	16
Long Term Investments	1,021	1,004	882	959	1,165	1,279	1,388	1,093	399	413	163	169
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	193	156	119	107	95	76	64	60	53	46	38	3
Assets Noncurrent	1,585	1,535	1,375	1,404	1,590	1,662	1,723	1,346	606	574	312	201
Assets	3,138	3,348	3,003	3,172	3,305	3,378	3,511	3,560	2,087	2,091	1,408	1,496
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	101	63	71	49	31	21	48	18	10	22	15	16
Employee Related Liabilities Current	14	8	23	17	11	6	21	12	6	3	11	7
Accrued Liabilities Current	25	30	31	25	32	26	29	31	22	54	60	15
Operating Lease Liability Current	7	6	6	6	6	6	6	10	7	7	7	6
Liabilities Current	271	242	206	200	154	97	140	124	83	87	145	86
Operating Lease Liability Noncurrent	109	110	111	79	80	81	65	18	18	20	22	8
Other Liabilities Noncurrent	-	-	0	-	-	-	0	-	-	-	0	0
Liabilities	380	352	317	279	234	178	205	142	101	107	167	93
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	5,525	5,478	4,839	4,800	4,769	4,729	4,698	4,669	3,132	3,000	2,165	2,148
Accumulated Other Comprehensive Income Loss Net Of…	-8	-7	2	1	-2	-0	-4	0	2	3	0	-2
Retained Earnings Accumulated Deficit	-2,760	-2,476	-2,155	-1,908	-1,696	-1,529	-1,388	-1,251	-1,148	-1,019	-924	-744
Stockholders Equity	2,758	2,996	2,686	2,893	3,071	3,200	3,306	3,418	1,986	1,984	1,240	1,403
Liabilities And Stockholders Equity	3,138	3,348	3,003	3,172	3,305	3,378	3,511	3,560	2,087	2,091	1,408	1,496
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	145	144	131	130	130	129	125	124	111	109	95	95
Shares Outstanding	145	144	131	130	130	129	125	124	111	109	95	95

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-9.98%	-1.02%	-4.27%	-	-	-	-	-	-	-	-	-
2025	12.03%	12.34%	26.31%	-6.70%	2.97%	27.97%	19.98%	13.59%	27.52%	-10.81%	1.63%	-14.60%
2024	5.21%	13.06%	25.84%	9.24%	53.04%	52.77%	-12.29%	-24.72%	-16.66%	-5.91%	-61.37%	-59.86%
2023	-	-	-	8.66%	4.32%	-3.83%	11.52%	30.16%	33.28%	-17.05%	-24.95%	-8.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.72	7.49	7.91	8.83	11.11	17.70	12.75	17.88	17.88	17.42	7.54	15.14
Quick Ratio	5.48	7.18	7.59	8.55	10.75	17.24	12.46	17.61	17.53	17.07	7.43	14.79
Working Capital	1.28B	1.57B	1.42B	1.57B	1.56B	1.62B	1.65B	2.09B	1.40B	1.43B	950.62M	1.21B
Leverage & Debt
Debt to Equity	0.14	0.12	0.12	0.10	0.08	0.06	0.06	0.04	0.05	0.05	0.13	0.07
Debt Ratio	0.12	0.11	0.11	0.09	0.07	0.05	0.06	0.04	0.05	0.05	0.12	0.06
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-7.37	-6.78	-5.63	-4.83	-4.02	-3.76	-3.80	-4.10	-4.24	-3.91	-4.14	-2.95
Free Cash Flow Per Share TTM	-5.42	-5.65	-4.97	-2.88	-2.29	-3.55	-3.89	-3.99	-4.20	-3.84	-3.26	-2.45
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	94.39%	85.73%	65.25%	29.46%	10.12%	16.67%	15.33%	69.49%	87.78%	78.32%	80.00%	72.14%
EPS Growth (1Y)	83.01%	80.65%	48.14%	17.58%	-5.08%	-3.97%	-8.15%	39.31%	57.04%	37.64%	20.19%	4.96%
Valuation Metrics
P/E TTM	-7.89	-8.56	-8.19	-7.46	-8.08	-10.05	-21.53	-27.84	-17.81	-17.47	-15.17	-17.30
P/B TTM	3.05	2.71	2.34	1.70	1.44	1.60	3.02	4.14	4.46	3.85	4.92	3.70
Market Cap	8.40B	8.11B	6.28B	4.91B	4.42B	5.12B	9.99B	14.13B	8.85B	7.63B	6.10B	5.18B
Enterprise Value	8.21B	7.84B	6.10B	4.62B	4.11B	4.78B	9.60B	13.08B	8.34B	7.02B	5.70B	4.64B
Calculated Values
Free Cash Flow TTM	-783.10M	-787.55M	-676.52M	-392.75M	-311.28M	-481.95M	-475.05M	-493.70M	-492.93M	-428.64M	-317.13M	-249.44M
Net Debt	-184.66M	-262.31M	-175.43M	-282.55M	-308.06M	-348.17M	-389.20M	-1.05B	-518.67M	-612.62M	-398.55M	-546.24M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Pickering, Grant

Title: CHIEF EXECUTIVE OFFICER

Shares: 22,237

Price/Share: $55.22

Value: $1,227,927.14

Shares Owned: 452,466

Relationship: Director,Officer

Ownership: Direct

2026-06-18Sale

Owner: Guggenhime, Andrew

Title: PRESIDENT AND CFO

Shares: 10,000

Price/Share: $53.00

Value: $530,000.00

Shares Owned: 104,395

Relationship: Officer

Ownership: Direct

2026-06-18Sale

Owner: Pickering, Grant

Title: CHIEF EXECUTIVE OFFICER

Shares: 22,461

Price/Share: $52.50

Value: $1,179,202.50

Shares Owned: 474,703

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Wassil, Jim

Title: CHIEF OPERATING OFFICER

Shares: 2,250

Price/Share: $49.83

Value: $112,117.50

Shares Owned: 158,494

Relationship: Officer

Ownership: Direct

2026-05-01Sale

Owner: Wassil, Jim

Title: CHIEF OPERATING OFFICER

Shares: 2,250

Price/Share: $56.83

Value: $127,867.50

Shares Owned: 160,744

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	22,237	55.22	$1,227,927.14	452,466	4
2026-06-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	10,000	53.00	$530,000.00	104,395	4
2026-06-18	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	22,461	52.50	$1,179,202.50	474,703	4
2026-06-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	2,250	49.83	$112,117.50	158,494	4
2026-05-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	2,250	56.83	$127,867.50	160,744	4
2026-04-07	Cowan, Elvia	Officer	SVP, Finance & CAO	Direct	Sale	3,000	60.00	$180,000.00	28,975	4
2026-04-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	2,250	58.54	$131,715.00	162,994	4
2026-03-17	Cowan, Elvia	Officer	SVP, Finance & CAO	Direct	Sale	1,892	55.82	$105,611.44	28,975	4
2026-03-11	Cowan, Elvia	Officer	SVP, Finance & CAO	Direct	Sale	2,500	58.59	$146,475.00	30,867	4
2026-03-10	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	7,395	58.74	$434,382.30	166,818	4
2025-12-31	Dhaliwal, Harpreet S.	Officer	Chief Technical Ops Officer	Direct	Sale	9,743	46.69	$454,900.67	23,928	4
2025-12-23	Cowan, Elvia	Officer	SVP, FINANCE	Direct	Sale	11,623	47.92	$556,974.16	14,534	4
2025-03-05	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	71.28	$356,400.00	41,620	4
2025-03-03	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	73.46	$587,680.00	154,931	4
2025-02-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	84.11	$672,880.00	109,491	4
2025-02-05	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	89.91	$449,550.00	28,222	4
2025-02-03	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	86.87	$694,960.00	205,695	4
2025-01-21	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	87.01	$696,080.00	109,491	4
2025-01-15	Loxam, Teri	Director	-	Direct	Sale	6,250	84.54	$528,375.00	7,175	4
2025-01-06	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	85.70	$428,500.00	28,222	4
2025-01-02	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	83.67	$669,360.00	205,695	4
2024-12-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	88.88	$711,040.00	109,491	4
2024-12-09	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,366	92.70	$219,328.20	136,215	4
2024-12-05	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	91.66	$458,300.00	28,697	4
2024-12-02	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	93.06	$1,395,900.00	450,301	4
2024-12-02	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	93.06	$744,480.00	205,695	4
2024-11-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	86.38	$691,040.00	109,491	4
2024-11-07	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,366	104.07	$246,229.62	137,398	4
2024-11-05	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	106.21	$531,050.00	28,623	4
2024-11-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	107.68	$861,440.00	205,695	4
2024-11-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	107.40	$1,611,000.00	435,219	4
2024-10-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	42,000	115.72	$4,860,240.00	90,383	4
2024-10-07	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	7,098	108.98	$773,540.04	138,581	4
2024-10-07	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,000	109.59	$547,950.00	28,623	4
2024-10-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	8,000	114.23	$913,840.00	200,646	4
2024-10-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	5,500	114.25	$628,375.00	28,623	4
2024-10-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	55,000	114.19	$6,280,450.00	450,219	4
2024-09-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	116.47	$931,760.00	90,383	4
2024-09-17	Loxam, Teri	Director	-	Direct	Sale	6,250	116.02	$725,125.00	7,175	4
2024-09-16	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	10,000	116.05	$1,160,500.00	200,646	4
2024-09-03	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	112.94	$188,270.98	30,826	4
2024-09-03	Cowan, Elvia	Officer	SVP, FINANCE	Direct	Sale	5,000	107.67	$538,350.00	12,723	4
2024-09-03	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	10,000	112.97	$1,129,700.00	207,503	4
2024-08-23	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	78.95	$1,184,250.00	478,888	4
2024-08-19	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	78.69	$629,520.00	96,720	4
2024-08-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	79.04	$131,759.68	30,826	4
2024-08-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	79.16	$237,480.00	207,503	4
2024-08-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	78.79	$206,114.64	142,130	4
2024-07-23	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	84.18	$1,262,700.00	478,888	4
2024-07-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	81.66	$653,280.00	96,720	4
2024-07-16	Cowan, Elvia	Officer	SVP, FINANCE	Direct	Sale	5,000	85.00	$425,000.00	12,723	4
2024-07-08	Cowan, Elvia	Officer	SVP, FINANCE	Direct	Sale	5,000	80.00	$400,000.00	12,723	4
2024-07-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	76.42	$127,392.14	30,826	4
2024-07-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	76.38	$199,810.08	143,438	4
2024-07-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	76.56	$229,680.00	210,503	4
2024-06-24	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	76.12	$1,141,800.00	478,888	4
2024-06-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	72.22	$577,760.00	96,720	4
2024-06-03	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	72.39	$217,170.00	213,503	4
2024-06-03	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	72.50	$189,660.00	144,746	4
2024-06-03	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	72.42	$120,724.14	31,161	4
2024-06-03	Gilbert, Halley E	Director	-	Direct	Sale	18,200	73.00	$1,328,600.00	5,625	4
2024-05-23	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	69.34	$1,040,100.00	477,847	4
2024-05-20	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	74.93	$599,440.00	95,679	4
2024-05-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	62.38	$103,987.46	30,597	4
2024-05-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	62.39	$163,212.24	146,054	4
2024-05-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	62.29	$186,870.00	215,462	4
2024-04-23	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	61.92	$928,800.00	477,847	4
2024-04-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	61.57	$492,560.00	95,679	4
2024-04-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	66.88	$200,640.00	218,289	4
2024-04-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	67.12	$175,585.92	147,362	4
2024-04-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	67.00	$111,689.00	30,597	4
2024-03-25	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	67.18	$1,007,700.00	477,847	4
2024-03-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	69.32	$554,560.00	95,679	4
2024-03-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	73.80	$123,024.60	31,210	4
2024-03-01	Cowan, Elvia	Officer	SVP, FINANCE	Direct	Sale	11,678	73.89	$862,887.42	12,480	4
2024-03-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	73.80	$221,400.00	220,852	4
2024-03-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	73.77	$192,982.32	148,670	4
2024-02-26	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	30,000	79.03	$2,370,900.00	375,814	4
2024-02-20	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	75.02	$600,160.00	79,474	4
2024-02-01	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Indirect	Sale	2,616	73.79	$193,034.64	149,978	4
2024-02-01	Wassil, Jim	Officer	CHIEF OPERATING OFFICER	Direct	Sale	3,000	73.74	$221,220.00	175,935	4
2024-02-01	Eydelman, Mikhail	Officer	SVP, GEN COUNSEL & CORP SEC	Direct	Sale	1,667	73.72	$122,891.24	20,710	4
2024-01-31	Lukatch, Heath	Director	-	Direct	Sale	5,000	71.50	$357,500.00	5,625	4
2024-01-29	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	30,000	66.03	$1,980,900.00	375,814	4
2024-01-29	Lukatch, Heath	Director	-	Direct	Sale	4,000	67.50	$270,000.00	5,625	4
2024-01-23	Pickering, Grant	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	15,000	63.98	$959,700.00	375,814	4
2024-01-18	Guggenhime, Andrew	Officer	PRESIDENT AND CFO	Direct	Sale	8,000	61.68	$493,440.00	79,474	4
2024-01-02	Wassil, Jim	Officer	Chief Operating Officer	Direct	Sale	3,000	63.92	$191,760.00	175,935	4
2024-01-02	Pickering, Grant	Director,Officer	Chief Executive Officer	Indirect	Sale	2,616	63.62	$166,429.92	151,286	4
2024-01-02	Eydelman, Mikhail	Officer	SVP, Gen Counsel & Corp Sec	Direct	Sale	1,667	63.60	$106,021.20	20,710	4
2024-01-02	Lukatch, Heath	Director	-	Direct	Sale	13,000	63.97	$831,610.00	5,625	4
2023-12-26	Pickering, Grant	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	61.70	$925,500.00	375,814	4
2023-12-18	Guggenhime, Andrew	Officer	President and CFO	Direct	Sale	8,000	60.48	$483,840.00	79,474	4
2023-12-14	Guggenhime, Andrew	Officer	President and CFO	Direct	Sale	14,000	60.22	$843,080.00	79,474	4
2023-12-07	Eydelman, Mikhail	Officer	SVP, Gen Counsel & Corp Sec	Direct	Sale	10,000	56.50	$565,000.00	21,035	4
2023-12-01	Wassil, Jim	Officer	Chief Operating Officer	Direct	Sale	3,000	51.98	$155,940.00	175,935	4
2023-12-01	Pickering, Grant	Director,Officer	Chief Executive Officer	Indirect	Sale	2,618	52.08	$136,345.44	152,594	4
2023-11-24	Pickering, Grant	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	49.21	$738,150.00	370,914	4
2023-11-20	Guggenhime, Andrew	Officer	President and CFO	Direct	Sale	8,000	51.54	$412,320.00	79,474	4
2023-11-01	Wassil, Jim	Officer	Chief Operating Officer	Direct	Sale	3,000	47.67	$143,010.00	175,935	4
2023-11-01	Pickering, Grant	Director,Officer	Chief Executive Officer	Indirect	Sale	2,618	47.70	$124,878.60	153,903	4
2023-10-23	Pickering, Grant	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	47.16	$707,400.00	385,914	4
2023-10-18	Guggenhime, Andrew	Officer	President and CFO	Direct	Sale	8,000	46.10	$368,800.00	79,474	4
2023-10-02	Wassil, Jim	Officer	Chief Operating Officer	Direct	Sale	3,000	50.66	$151,980.00	170,935	4
2023-10-02	Eydelman, Mikhail	Officer	SVP, Gen Counsel & Corp Sec	Direct	Sale	20,000	50.41	$1,008,200.00	20,487	4
2023-10-02	Pickering, Grant	Director,Officer	Chief Executive Officer	Indirect	Sale	2,618	50.61	$132,496.98	155,212	4
2023-09-25	Pickering, Grant	Director,Officer	Chief Executive Officer	Direct	Sale	15,000	52.45	$786,750.00	400,914	4
2023-09-01	Wassil, Jim	Officer	Chief Operating Officer	Direct	Sale	3,000	53.06	$159,180.00	170,066	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

105.21%

Inst. Shares: 146,775,945

Shares Outstanding: 139,506,680

2025-12-31

98.83%

Inst. Shares: 134,492,541

Shares Outstanding: 136,089,506

2025-09-30

95.74%

Inst. Shares: 130,399,443

Shares Outstanding: 136,196,512

2025-06-30

100.43%

Inst. Shares: 136,621,422

Shares Outstanding: 136,033,746

2025-03-31

101.24%

Inst. Shares: 137,374,933

Shares Outstanding: 135,690,949

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	146,775,945	139,506,680	105.21%
2025-12-31	134,492,541	136,089,506	98.83%
2025-09-30	130,399,443	136,196,512	95.74%
2025-06-30	136,621,422	136,033,746	100.43%
2025-03-31	137,374,933	135,690,949	101.24%
2024-12-31	132,474,668	121,997,348	108.59%
2024-09-30	125,956,638	123,693,461	101.83%
2024-06-30	114,661,068	117,256,561	97.79%
2024-03-31	110,483,697	111,690,951	98.92%
2023-12-31	98,212,706	97,157,690	101.09%
2023-09-30	96,455,523	101,668,655	94.87%
2023-06-30	95,480,124	98,057,870	97.37%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Vaxcyte, Inc. (PCVX) — SEC Financial Statements & Analysis

Vaxcyte, Inc. (PCVX) is a biological products, (no diagnostic substances) company, incorporated in DE. Vaxcyte, Inc. trades on Nasdaq as: PCVX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Vaxcyte, Inc. reported a Debt-to-Equity ratio of 0.14x, a Price-to-Book (P/B) ratio of 3.05x (TTM), at a market cap of $8.40B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.14x
P/B TTM: 3.05x
Market Cap: $8.40B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Vaxcyte, Inc. in?

Vaxcyte, Inc. (PCVX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is PCVX's market cap?

Vaxcyte, Inc. (PCVX) has a market capitalization of $8.40B as of 2026-06-30.

What exchange does PCVX trade on?

Vaxcyte, Inc. (PCVX) trades on the Nasdaq.

Where is Vaxcyte, Inc. incorporated?

Vaxcyte, Inc. is incorporated in DE.

Vaxcyte, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Vaxcyte, Inc. (PCVX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

Vaxcyte, Inc. (PCVX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.